DK1107795T3 - Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis - Google Patents
Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritisInfo
- Publication number
- DK1107795T3 DK1107795T3 DK99952903T DK99952903T DK1107795T3 DK 1107795 T3 DK1107795 T3 DK 1107795T3 DK 99952903 T DK99952903 T DK 99952903T DK 99952903 T DK99952903 T DK 99952903T DK 1107795 T3 DK1107795 T3 DK 1107795T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- cancer
- thiomolybdate
- carbohydrate
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000001594 aberrant effect Effects 0.000 title 1
- 150000001720 carbohydrates Chemical class 0.000 title 1
- 208000002780 macular degeneration Diseases 0.000 title 1
- 206010039073 rheumatoid arthritis Diseases 0.000 title 1
- CXVCSRUYMINUSF-UHFFFAOYSA-N tetrathiomolybdate(2-) Chemical compound [S-][Mo]([S-])(=S)=S CXVCSRUYMINUSF-UHFFFAOYSA-N 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9910398P | 1998-09-04 | 1998-09-04 | |
| US10175998P | 1998-09-25 | 1998-09-25 | |
| PCT/US1999/020374 WO2000013712A2 (en) | 1998-09-04 | 1999-09-03 | Methods and compositions for the prevention or treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1107795T3 true DK1107795T3 (da) | 2003-03-24 |
Family
ID=26795562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99952903T DK1107795T3 (da) | 1998-09-04 | 1999-09-03 | Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1107795B1 (da) |
| JP (1) | JP2002524426A (da) |
| KR (1) | KR100702279B1 (da) |
| CN (1) | CN100548383C (da) |
| AT (1) | ATE228375T1 (da) |
| AU (1) | AU773848B2 (da) |
| CA (1) | CA2341752A1 (da) |
| DE (1) | DE69904203T2 (da) |
| DK (1) | DK1107795T3 (da) |
| ES (1) | ES2188261T3 (da) |
| IL (1) | IL141550A0 (da) |
| NZ (1) | NZ510038A (da) |
| PT (1) | PT1107795E (da) |
| WO (1) | WO2000013712A2 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6703050B1 (en) | 1998-09-04 | 2004-03-09 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
| US7632803B2 (en) | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| US7592304B2 (en) | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| US20070292533A1 (en) * | 2002-05-24 | 2007-12-20 | Regents Of The University Of Michigan | Copper lowering treatment of autoimmune diseases |
| US6855340B2 (en) * | 2002-05-24 | 2005-02-15 | Regents Of The University Of Michigan | Copper lowering treatment of inflammatory and fibrotic diseases |
| US7189865B2 (en) * | 2002-07-23 | 2007-03-13 | Attenuon, Llc | Thiomolybdate analogues and uses thereof |
| MXPA05000875A (es) | 2002-07-23 | 2005-09-30 | Univ Michigan | Tetratiomolibdato de tetrapropilamonio y compuestos relacionados para terapias anti-angiogenicas. |
| CN100558409C (zh) * | 2003-05-27 | 2009-11-11 | 阿特努奥恩公司 | 硫代钨酸盐类似物及其用途 |
| WO2005083107A2 (en) * | 2004-02-24 | 2005-09-09 | Attenuon Llp | Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic and antitumor agents |
| EP1993607A4 (en) * | 2006-01-10 | 2012-03-28 | Pipex Inc | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR OBTAINING AND MAINTAINING A TARGETABLE, STABLE COPPER RATE AND PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES RELATED TO SERIAL COPPER RATE |
| WO2009009622A2 (en) * | 2007-07-09 | 2009-01-15 | Pipex Pharmaceuticals, Inc. | Pharmaceutical compositions, including attm, and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| KR100972355B1 (ko) * | 2008-05-08 | 2010-07-26 | 고려전자주식회사 | 순간식 가스보일러의 온수공급라인용 써모밸브조립체 |
| US10478455B2 (en) | 2010-03-30 | 2019-11-19 | Ucl Business Ltd | Therapeutic use of tetrathiomolybdate |
| GB201005394D0 (en) * | 2010-03-30 | 2010-05-12 | Magnus Intellectual Property Ltd | Therapy |
| US20160220500A1 (en) * | 2014-11-14 | 2016-08-04 | Kent State University | Targeting Intracellular Copper Ions for Inhibiting Angiogenesis Using Nanoparticles of Ternary Inorganic Metal Sulfide M1M2S4 (M1, independently, is Mg, Ca, Mn, Fe, or Zn; M2 = Mo or W) Compounds to Treat Metastatic Cancer |
| CN108634322A (zh) * | 2018-05-16 | 2018-10-12 | 刘华 | 一种预防和调理癌症的方法 |
| WO2019232188A1 (en) * | 2018-06-01 | 2019-12-05 | Incyte Corporation | Dosing regimen for the treatment of pi3k related disorders |
-
1999
- 1999-09-03 JP JP2000568518A patent/JP2002524426A/ja active Pending
- 1999-09-03 ES ES99952903T patent/ES2188261T3/es not_active Expired - Lifetime
- 1999-09-03 WO PCT/US1999/020374 patent/WO2000013712A2/en not_active Ceased
- 1999-09-03 CN CNB998117331A patent/CN100548383C/zh not_active Expired - Fee Related
- 1999-09-03 EP EP99952903A patent/EP1107795B1/en not_active Expired - Lifetime
- 1999-09-03 KR KR1020017002840A patent/KR100702279B1/ko not_active Expired - Fee Related
- 1999-09-03 PT PT99952903T patent/PT1107795E/pt unknown
- 1999-09-03 CA CA002341752A patent/CA2341752A1/en not_active Abandoned
- 1999-09-03 DK DK99952903T patent/DK1107795T3/da active
- 1999-09-03 DE DE69904203T patent/DE69904203T2/de not_active Expired - Lifetime
- 1999-09-03 AU AU64960/99A patent/AU773848B2/en not_active Ceased
- 1999-09-03 IL IL14155099A patent/IL141550A0/xx unknown
- 1999-09-03 AT AT99952903T patent/ATE228375T1/de not_active IP Right Cessation
- 1999-09-03 NZ NZ510038A patent/NZ510038A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2341752A1 (en) | 2000-03-16 |
| DE69904203D1 (de) | 2003-01-09 |
| PT1107795E (pt) | 2003-04-30 |
| AU773848B2 (en) | 2004-06-10 |
| KR20010082190A (ko) | 2001-08-29 |
| JP2002524426A (ja) | 2002-08-06 |
| KR100702279B1 (ko) | 2007-04-02 |
| AU6496099A (en) | 2000-03-27 |
| DE69904203T2 (de) | 2003-08-14 |
| NZ510038A (en) | 2003-10-31 |
| ATE228375T1 (de) | 2002-12-15 |
| CN1457261A (zh) | 2003-11-19 |
| WO2000013712A2 (en) | 2000-03-16 |
| ES2188261T3 (es) | 2003-06-16 |
| WO2000013712A3 (en) | 2000-09-28 |
| EP1107795A2 (en) | 2001-06-20 |
| IL141550A0 (en) | 2002-03-10 |
| EP1107795B1 (en) | 2002-11-27 |
| CN100548383C (zh) | 2009-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1107795T3 (da) | Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis | |
| CY1123084T1 (el) | Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι | |
| SI2269656T1 (sl) | Izbrana protitelesa, ki se veĹľejo na aminofosfolipide, in njihova uporaba v zdravljanju raka | |
| WO2004052280A3 (en) | Anti-angiogenic compounds and their use in cancer treatment | |
| HUT76970A (hu) | Készítmény az érrendszer specifikus koagulálásához | |
| NZ332721A (en) | Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders | |
| WO2005055944A3 (en) | Oligosaccharide compositions and use thereof in the treatment of infection | |
| SI1615952T1 (sl) | Metoda zdravljenja vnetnih bolezni z uporabo specifičnih veznih sredstev humanega angiopoetin | |
| IL146125A0 (en) | Novel quinones as disease therapies | |
| EP1790728A3 (en) | Imaging, diagnosis and treatment of disease | |
| MXPA03008423A (es) | Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias. | |
| TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
| WO2003017939A3 (en) | Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment | |
| WO2004099388A3 (en) | Cbl-b polypeptides, complexes and related methods | |
| WO2003035688A3 (en) | Targeted thrombosis by tissue factor polypeptides | |
| MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
| EP0281070A3 (en) | Pharmaceutical composition for the treatment of cancer | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| EP1234585A3 (en) | Methods and compositions for the prevention or treatment of cancer | |
| NO20006699L (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
| DK1253935T3 (da) | Anvendelse af placenta-vækstfaktor til forebyggelse eller behandling af iskæmiske sygdomme eller slagtilfælde | |
| DK1196188T3 (da) | VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser | |
| NZ514691A (en) | Method to type prion proteins |